Submit Search
Upload
Ann ginsberg
•
2 likes
•
1,181 views
Rosella Anstine
Follow
Health & Medicine
Business
Report
Share
Report
Share
1 of 37
Download now
Download to read offline
Recommended
Arne naveke
Arne naveke
Rosella Anstine
Angeline nanni
Angeline nanni
Rosella Anstine
Social and behavioral determinants lit review
Social and behavioral determinants lit review
Rosella Anstine
David curry
David curry
Rosella Anstine
Amanda glassman
Amanda glassman
Rosella Anstine
Unicef o'connell equity and vaccine supply 5_sep13
Unicef o'connell equity and vaccine supply 5_sep13
Rosella Anstine
David K. Robinson, Ph. D.Vice President, BiologicsHead and Executive Director, Biologics and Vaccines CMC RegulatoryMerck & Co, Inc. Presenting on behalf of the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA)WCBP CASS, Washington DC, USAJanuary 2014
IFPMA: From Manufacturing to the Vaccinee – the Complex Journey of a Vaccine
IFPMA: From Manufacturing to the Vaccinee – the Complex Journey of a Vaccine
International Federation of Pharmaceutical Manufacturers & Associations (IFPMA)
How to Prevent future pandemics
How to prevent future pandemics
How to prevent future pandemics
AyanMohanta2
Recommended
Arne naveke
Arne naveke
Rosella Anstine
Angeline nanni
Angeline nanni
Rosella Anstine
Social and behavioral determinants lit review
Social and behavioral determinants lit review
Rosella Anstine
David curry
David curry
Rosella Anstine
Amanda glassman
Amanda glassman
Rosella Anstine
Unicef o'connell equity and vaccine supply 5_sep13
Unicef o'connell equity and vaccine supply 5_sep13
Rosella Anstine
David K. Robinson, Ph. D.Vice President, BiologicsHead and Executive Director, Biologics and Vaccines CMC RegulatoryMerck & Co, Inc. Presenting on behalf of the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA)WCBP CASS, Washington DC, USAJanuary 2014
IFPMA: From Manufacturing to the Vaccinee – the Complex Journey of a Vaccine
IFPMA: From Manufacturing to the Vaccinee – the Complex Journey of a Vaccine
International Federation of Pharmaceutical Manufacturers & Associations (IFPMA)
How to Prevent future pandemics
How to prevent future pandemics
How to prevent future pandemics
AyanMohanta2
Recent advances and remaining global challenges in control of meningococcal disease. https://www.meningitis.org/mrf-conference-2017
Prof David Stephens @ Meningitis & Septicaemia in Children & Adults
Prof David Stephens @ Meningitis & Septicaemia in Children & Adults
Meningitis Research Foundation
Global burden of meningitis, understanding modelled estimates and the meningitis progress tracker
Claire Wright @ MRF's Meningitis and Septicaemia 2019
Claire Wright @ MRF's Meningitis and Septicaemia 2019
Meningitis Research Foundation
present strategy in INDIA for Measles elimination
GLOBAL STRATEGY FOR MEASLES ELIMINATION
GLOBAL STRATEGY FOR MEASLES ELIMINATION
Preetam Kar
The slideset by professor Paolo Bonanni on vaccination in adults makes an overview on influenza, streptococcus pneumoniae, diphtheria, tetanus, pertussis, Human Papilloma Virus (HPV), measles, mumps, rubella, varicella and tick borne encephalitis. Where we were and where we are.
Vaccination in adults - Slideset by Professor Paolo Bonanni
Vaccination in adults - Slideset by Professor Paolo Bonanni
WAidid
Defeating meningitis by 2030
Dr Marie-Pierre Preziosi @ MRF's Meningitis and Septicaemia 2019
Dr Marie-Pierre Preziosi @ MRF's Meningitis and Septicaemia 2019
Meningitis Research Foundation
Prospect for a GBS vaccine and the pathway to licensure, including considerations for LMICs
Dr Kirsty Le Doare @ MRF's Meningitis and Septicaemia 2019
Dr Kirsty Le Doare @ MRF's Meningitis and Septicaemia 2019
Meningitis Research Foundation
Prospects for GBS prevention - current candidates & removing barriers to licensure of a GBS vaccine for pregnant women globally https://www.meningitis.org/mrf-conference-2017
Dr Kirsty Le Doare @ MRF's Meningitis & Septicaemia
Dr Kirsty Le Doare @ MRF's Meningitis & Septicaemia
Meningitis Research Foundation
What next for prevention of pneumococcal disease in light of serotype replacement? Is there a pathway to licensure for novel pneumococcal vaccines? https://www.meningitis.org/mrf-conference-2017
Prof Rick Malley @ Meningitis & Septicaemia in Children & Adults 2017
Prof Rick Malley @ Meningitis & Septicaemia in Children & Adults 2017
Meningitis Research Foundation
Who day – 2014 a global brief on vector borne diseases.
Who day – 2014 a global brief on vector borne diseases.
Dr. Dharmendra Gahwai
"Role of vaccines in making the world a better place for children" - Slideset by professor Madhi (WAidid Board Member) presented at the 2015 World Congress of Nephrology, held in Cape Town from March 13-17 2015. Find more on www.waidid.org
Role of vaccines and child health - Professor Shabir Madhi
Role of vaccines and child health - Professor Shabir Madhi
WAidid
30 November 2016, Washington DC IFPMA Assembly 2016: Global Health V.2.0 Challenges in a Changing World
Peter Hotez, Baylor College of Medicine
Peter Hotez, Baylor College of Medicine
International Federation of Pharmaceutical Manufacturers & Associations (IFPMA)
Combating Antimicrobial Resistance: The Way Forward - Dr. James Hughes, Professor of Medicine and Public Health with Joint Appointments in the School of Medicine and the Rollins School of Public Health at Emory University, from the 2014 NIAA Symposium on Antibiotics Use and Resistance: Moving Forward Through Shared Stewardship, November 12-14, 2014, Atlanta, Georgia, USA. More presentations at http://www.swinecast.com/2014-niaa-antibiotics-moving-forward-through-shared-stewardship
Dr. James Hughes - Combating Antimicrobial Resistance: The Way Forward
Dr. James Hughes - Combating Antimicrobial Resistance: The Way Forward
John Blue
Measles catch up campaign
Measles catch up campaign
Raghavendra Huchchannavar
Modelling the use of ciprofloxacin for epidemic response in the African meningitis belt
Dr Matt Coldiron @ MRF's Meningitis and Septicaemia
Dr Matt Coldiron @ MRF's Meningitis and Septicaemia
Meningitis Research Foundation
One type of surveillance system done for the vaccine prevantble infectious disease and serious AEFI reporting systems.
Vpd & IDsurv
Vpd & IDsurv
Ketan Patel
Explores relationships and discrepancies between important research-based medical advancements and subsequent real world implementation. Advancements in the management and potential elimination of infectious diseases such as HIV and TB will be addressed, as related to development and implementation of effective diagnostics, vaccines, or treatments.
From Discovery to Delivery: Benchwork to Global Health: Corey Casper
From Discovery to Delivery: Benchwork to Global Health: Corey Casper
UWGlobalHealth
WHO Global Tuberculosis report 2015
WHO Global Tuberculosis report 2015
WHO Global Tuberculosis report 2015
Niraj Bartaula
Meningococcal carriage in the African meningitis belt and the impact of MenAfriVac: an overview of the MenAfriCar project http://www.meningitis.org/conference2015
Prof Sir Brian Greenwood @ MRF's Meningitis & Septicaemia in Children & Adult...
Prof Sir Brian Greenwood @ MRF's Meningitis & Septicaemia in Children & Adult...
Meningitis Research Foundation
KCR features in the newest Pharma Voice, June 2017, top industry publication. Andrzej Piotrowski, MD, Ph.D., Medical Monitor at KCR, commented on malaria treatment and research.
PharmaVoice: Malaria Research Update
PharmaVoice: Malaria Research Update
KCR
HIV/AIDS & TB
HIV/AIDS & TB
MedicineAndHealthCancer
Join us in New Jersey this November for our Superbugs and Superdrugs 2017 conference
SMi Group's 2nd annual Superbugs & Superdrugs USA 2017 conference
SMi Group's 2nd annual Superbugs & Superdrugs USA 2017 conference
Dale Butler
Building on almost two decades worth of expertise in fighting the growing threat of antimicrobial resistance (AMR), SMi Group are thrilled to announce the return of Superbugs and Superdrugs USA which arrives to Iselin, New Jersey on November 13th & 14th 2017. Antimicrobial resistance has sparked an urgency in the development of new drugs as the industry strives for novel solutions to fight infectious diseases. Innovation and collaboration is requested at every level making Superbugs & Superdrugs USA, the perfect platform to strengthen knowledge in key principles such as funding incentives and global strategy, whilst honing in on clinical developments in areas such as immunotherapy, toxoid based vaccines and anti-body drug conjugates. As methods move away from traditional small molecule antibiotics, this is critical time for AMR experts, government bodies and industry leaders, to come together and share ideas on the latest developments in treatment and prevention. Featured speakers include: Janssen, UNT Health Science Center, John Rex from CARB-X, BARDA, Pfizer, Merck, DemovaMed, Visterrra, Microbiotix more.
Superbugs and Superdrugs USA
Superbugs and Superdrugs USA
Teri Arri
More Related Content
What's hot
Recent advances and remaining global challenges in control of meningococcal disease. https://www.meningitis.org/mrf-conference-2017
Prof David Stephens @ Meningitis & Septicaemia in Children & Adults
Prof David Stephens @ Meningitis & Septicaemia in Children & Adults
Meningitis Research Foundation
Global burden of meningitis, understanding modelled estimates and the meningitis progress tracker
Claire Wright @ MRF's Meningitis and Septicaemia 2019
Claire Wright @ MRF's Meningitis and Septicaemia 2019
Meningitis Research Foundation
present strategy in INDIA for Measles elimination
GLOBAL STRATEGY FOR MEASLES ELIMINATION
GLOBAL STRATEGY FOR MEASLES ELIMINATION
Preetam Kar
The slideset by professor Paolo Bonanni on vaccination in adults makes an overview on influenza, streptococcus pneumoniae, diphtheria, tetanus, pertussis, Human Papilloma Virus (HPV), measles, mumps, rubella, varicella and tick borne encephalitis. Where we were and where we are.
Vaccination in adults - Slideset by Professor Paolo Bonanni
Vaccination in adults - Slideset by Professor Paolo Bonanni
WAidid
Defeating meningitis by 2030
Dr Marie-Pierre Preziosi @ MRF's Meningitis and Septicaemia 2019
Dr Marie-Pierre Preziosi @ MRF's Meningitis and Septicaemia 2019
Meningitis Research Foundation
Prospect for a GBS vaccine and the pathway to licensure, including considerations for LMICs
Dr Kirsty Le Doare @ MRF's Meningitis and Septicaemia 2019
Dr Kirsty Le Doare @ MRF's Meningitis and Septicaemia 2019
Meningitis Research Foundation
Prospects for GBS prevention - current candidates & removing barriers to licensure of a GBS vaccine for pregnant women globally https://www.meningitis.org/mrf-conference-2017
Dr Kirsty Le Doare @ MRF's Meningitis & Septicaemia
Dr Kirsty Le Doare @ MRF's Meningitis & Septicaemia
Meningitis Research Foundation
What next for prevention of pneumococcal disease in light of serotype replacement? Is there a pathway to licensure for novel pneumococcal vaccines? https://www.meningitis.org/mrf-conference-2017
Prof Rick Malley @ Meningitis & Septicaemia in Children & Adults 2017
Prof Rick Malley @ Meningitis & Septicaemia in Children & Adults 2017
Meningitis Research Foundation
Who day – 2014 a global brief on vector borne diseases.
Who day – 2014 a global brief on vector borne diseases.
Dr. Dharmendra Gahwai
"Role of vaccines in making the world a better place for children" - Slideset by professor Madhi (WAidid Board Member) presented at the 2015 World Congress of Nephrology, held in Cape Town from March 13-17 2015. Find more on www.waidid.org
Role of vaccines and child health - Professor Shabir Madhi
Role of vaccines and child health - Professor Shabir Madhi
WAidid
30 November 2016, Washington DC IFPMA Assembly 2016: Global Health V.2.0 Challenges in a Changing World
Peter Hotez, Baylor College of Medicine
Peter Hotez, Baylor College of Medicine
International Federation of Pharmaceutical Manufacturers & Associations (IFPMA)
Combating Antimicrobial Resistance: The Way Forward - Dr. James Hughes, Professor of Medicine and Public Health with Joint Appointments in the School of Medicine and the Rollins School of Public Health at Emory University, from the 2014 NIAA Symposium on Antibiotics Use and Resistance: Moving Forward Through Shared Stewardship, November 12-14, 2014, Atlanta, Georgia, USA. More presentations at http://www.swinecast.com/2014-niaa-antibiotics-moving-forward-through-shared-stewardship
Dr. James Hughes - Combating Antimicrobial Resistance: The Way Forward
Dr. James Hughes - Combating Antimicrobial Resistance: The Way Forward
John Blue
Measles catch up campaign
Measles catch up campaign
Raghavendra Huchchannavar
Modelling the use of ciprofloxacin for epidemic response in the African meningitis belt
Dr Matt Coldiron @ MRF's Meningitis and Septicaemia
Dr Matt Coldiron @ MRF's Meningitis and Septicaemia
Meningitis Research Foundation
One type of surveillance system done for the vaccine prevantble infectious disease and serious AEFI reporting systems.
Vpd & IDsurv
Vpd & IDsurv
Ketan Patel
Explores relationships and discrepancies between important research-based medical advancements and subsequent real world implementation. Advancements in the management and potential elimination of infectious diseases such as HIV and TB will be addressed, as related to development and implementation of effective diagnostics, vaccines, or treatments.
From Discovery to Delivery: Benchwork to Global Health: Corey Casper
From Discovery to Delivery: Benchwork to Global Health: Corey Casper
UWGlobalHealth
WHO Global Tuberculosis report 2015
WHO Global Tuberculosis report 2015
WHO Global Tuberculosis report 2015
Niraj Bartaula
Meningococcal carriage in the African meningitis belt and the impact of MenAfriVac: an overview of the MenAfriCar project http://www.meningitis.org/conference2015
Prof Sir Brian Greenwood @ MRF's Meningitis & Septicaemia in Children & Adult...
Prof Sir Brian Greenwood @ MRF's Meningitis & Septicaemia in Children & Adult...
Meningitis Research Foundation
KCR features in the newest Pharma Voice, June 2017, top industry publication. Andrzej Piotrowski, MD, Ph.D., Medical Monitor at KCR, commented on malaria treatment and research.
PharmaVoice: Malaria Research Update
PharmaVoice: Malaria Research Update
KCR
What's hot
(19)
Prof David Stephens @ Meningitis & Septicaemia in Children & Adults
Prof David Stephens @ Meningitis & Septicaemia in Children & Adults
Claire Wright @ MRF's Meningitis and Septicaemia 2019
Claire Wright @ MRF's Meningitis and Septicaemia 2019
GLOBAL STRATEGY FOR MEASLES ELIMINATION
GLOBAL STRATEGY FOR MEASLES ELIMINATION
Vaccination in adults - Slideset by Professor Paolo Bonanni
Vaccination in adults - Slideset by Professor Paolo Bonanni
Dr Marie-Pierre Preziosi @ MRF's Meningitis and Septicaemia 2019
Dr Marie-Pierre Preziosi @ MRF's Meningitis and Septicaemia 2019
Dr Kirsty Le Doare @ MRF's Meningitis and Septicaemia 2019
Dr Kirsty Le Doare @ MRF's Meningitis and Septicaemia 2019
Dr Kirsty Le Doare @ MRF's Meningitis & Septicaemia
Dr Kirsty Le Doare @ MRF's Meningitis & Septicaemia
Prof Rick Malley @ Meningitis & Septicaemia in Children & Adults 2017
Prof Rick Malley @ Meningitis & Septicaemia in Children & Adults 2017
Who day – 2014 a global brief on vector borne diseases.
Who day – 2014 a global brief on vector borne diseases.
Role of vaccines and child health - Professor Shabir Madhi
Role of vaccines and child health - Professor Shabir Madhi
Peter Hotez, Baylor College of Medicine
Peter Hotez, Baylor College of Medicine
Dr. James Hughes - Combating Antimicrobial Resistance: The Way Forward
Dr. James Hughes - Combating Antimicrobial Resistance: The Way Forward
Measles catch up campaign
Measles catch up campaign
Dr Matt Coldiron @ MRF's Meningitis and Septicaemia
Dr Matt Coldiron @ MRF's Meningitis and Septicaemia
Vpd & IDsurv
Vpd & IDsurv
From Discovery to Delivery: Benchwork to Global Health: Corey Casper
From Discovery to Delivery: Benchwork to Global Health: Corey Casper
WHO Global Tuberculosis report 2015
WHO Global Tuberculosis report 2015
Prof Sir Brian Greenwood @ MRF's Meningitis & Septicaemia in Children & Adult...
Prof Sir Brian Greenwood @ MRF's Meningitis & Septicaemia in Children & Adult...
PharmaVoice: Malaria Research Update
PharmaVoice: Malaria Research Update
Similar to Ann ginsberg
HIV/AIDS & TB
HIV/AIDS & TB
MedicineAndHealthCancer
Join us in New Jersey this November for our Superbugs and Superdrugs 2017 conference
SMi Group's 2nd annual Superbugs & Superdrugs USA 2017 conference
SMi Group's 2nd annual Superbugs & Superdrugs USA 2017 conference
Dale Butler
Building on almost two decades worth of expertise in fighting the growing threat of antimicrobial resistance (AMR), SMi Group are thrilled to announce the return of Superbugs and Superdrugs USA which arrives to Iselin, New Jersey on November 13th & 14th 2017. Antimicrobial resistance has sparked an urgency in the development of new drugs as the industry strives for novel solutions to fight infectious diseases. Innovation and collaboration is requested at every level making Superbugs & Superdrugs USA, the perfect platform to strengthen knowledge in key principles such as funding incentives and global strategy, whilst honing in on clinical developments in areas such as immunotherapy, toxoid based vaccines and anti-body drug conjugates. As methods move away from traditional small molecule antibiotics, this is critical time for AMR experts, government bodies and industry leaders, to come together and share ideas on the latest developments in treatment and prevention. Featured speakers include: Janssen, UNT Health Science Center, John Rex from CARB-X, BARDA, Pfizer, Merck, DemovaMed, Visterrra, Microbiotix more.
Superbugs and Superdrugs USA
Superbugs and Superdrugs USA
Teri Arri
2018: FIND AMR Strategy
2018: FIND AMR Strategy
2018: FIND AMR Strategy
SystemOne
TB Alliance's presentation at the Partnering for Cures, December 2, 2009
TB Alliance: Improving Treatments Against TB
TB Alliance: Improving Treatments Against TB
TRAIN Central Station
Join us in Iselin this November for our 3rd annual Superbugs and Superdrugs USA 2018 conference
SMi Group's Superbugs and Superdrugs USA 2018
SMi Group's Superbugs and Superdrugs USA 2018
Dale Butler
Advancing scientific Knowledge in times of Pandemics
Developing Therapeutic Strategies & Current Knowledge on Drugs For Treatment ...
Developing Therapeutic Strategies & Current Knowledge on Drugs For Treatment ...
LaraV1
September 2013 Corporate Presentation
Inovio sep13pres
Inovio sep13pres
Company Spotlight
Inovio sep13 presentation
Inovio sep13 presentation
Company Spotlight
MICROBIOLOGY IN CLINICAL PRACTICE what infection means?
MICROBIOLOGY IN CLINICAL PRACTICE what infection means ?